Biosimilars Forum Says 75% Market Share Could Save US Billions
As AAM Discourages Reducing Incentives For Patent Challenge And Early Generic Entry
Executive Summary
The Biosimilars Forum, in partnership with the Pacific Research Institute, has released a report that shows state-by-state cost savings for the US if biosimilars were able to capture a market share of 75%. Meanwhile, the Association for Accessible Medicines has also released its complete 2021 US Generic And Biosimilar Medicines Savings Report, discouraging reducing incentives for patent challenges and early generic entry.